JB
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sharbaugh, R. J.
Right arrow Articles by Grogan, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharbaugh, R. J.
Right arrow Articles by Grogan, J. B.

 Previous Article  |  Next Article 

J Bacteriol. 1969 October; 100(1): 117-122
Copyright © 1969 American Society for Microbiology. All Rights Reserved.

Suppression of Reticuloendothelial Function in the Rat with Cyclophosphamide

Robert J. Sharbaugh1 and James B. Grogan2

1 Department of Microbiology, University of Mississippi Medical Center, Jackson, Mississippi 39216
2 Department of Surgery, University of Mississippi Medical Center, Jackson, Mississippi 39216

ABSTRACT

Effects of cyclophosphamide immunosuppressive therapy upon reticuloendothelial function in the rat have been studied. Numerous side effects including leukopenia, hematuria, diarrhea, hemorrhagic cystitis, and petechial hemorrhage in the lungs and the small bowel were observed. Studies utilizing 32P-labeled bacteria revealed no change in the ability of the liver, spleen, lungs, or kidneys to ingest Pseudomonas aeruginosa. Utilization of labeled Staphylococcus aureus revealed an impairment of splenic uptake in animals receiving the maximal dose of 100 mg/kg. However, the liver, lungs, and kidneys were not affected. Although no generalized defect in the ingestive powers of these organs was observed, the ability of the lungs and kidneys from treated animals to kill ingested bacteria was significantly impaired. Regardless of the bacterium employed, the lungs and kidneys revealed a decrease in bactericidal ability with increasing drug dosages. Neither the liver nor the spleen from treated animals exhibited any decrease in bactericidal effect. Possible causes of this reduction in the bactericidal ability of alveolar and renal tissue following immunosuppression with cyclophosphamide are discussed.


J Bacteriol. 1969 October; 100(1): 117-122
Copyright © 1969 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Appl. Environ. Microbiol. Infect. Immun. Eukaryot. Cell
Mol. Cell. Biol. J. Virol. Microbiol. Mol. Biol. Rev.
ALL ASM JOURNALS

Copyright © 1969 by the American Society for Microbiology. All rights reserved.